Beijing Tong Ren Tang Chinese Medicine Co akcijos akcijų analizė | Akcijų kaina | Naujienos | 3613.HK | HK0000145638 | A1XDB1

Data	Beijing Tong Ren Tang Chinese Medicine Co Akcijų kaina
2024-08-16	8,71 undefined
2024-08-15	8,73 undefined
2024-08-14	8,74 undefined
2024-08-13	8,78 undefined
2024-08-12	8,83 undefined
2024-08-09	8,90 undefined
2024-08-08	8,87 undefined
2024-08-07	8,85 undefined
2024-08-06	8,65 undefined
2024-08-05	8,39 undefined
2024-08-02	8,61 undefined
2024-08-01	8,53 undefined
2024-07-31	8,60 undefined
2024-07-30	8,28 undefined
2024-07-29	8,37 undefined
2024-07-26	8,50 undefined
2024-07-25	8,54 undefined
2024-07-24	8,59 undefined
2024-07-23	8,53 undefined
2024-07-22	8,69 undefined
2024-07-19	8,81 undefined

Data	Beijing Tong Ren Tang Chinese Medicine Co Pajamos	Beijing Tong Ren Tang Chinese Medicine Co EBIT	Beijing Tong Ren Tang Chinese Medicine Co Pelnas
2026e	2,18 mlrd. undefined	1,01 mlrd. undefined	802,61 mln. undefined
2025e	1,94 mlrd. undefined	880,35 mln. undefined	734,30 mln. undefined
2024e	1,71 mlrd. undefined	748,73 mln. undefined	627,57 mln. undefined
2023	1,52 mlrd. undefined	618,39 mln. undefined	540,39 mln. undefined
2022	1,73 mlrd. undefined	811,58 mln. undefined	645,88 mln. undefined
2021	1,56 mlrd. undefined	778,46 mln. undefined	607,84 mln. undefined
2020	1,32 mlrd. undefined	669,40 mln. undefined	542,46 mln. undefined
2019	1,43 mlrd. undefined	651,99 mln. undefined	556,12 mln. undefined
2018	1,51 mlrd. undefined	698,01 mln. undefined	580,72 mln. undefined
2017	1,27 mlrd. undefined	597,68 mln. undefined	489,97 mln. undefined
2016	1,08 mlrd. undefined	527,50 mln. undefined	420,32 mln. undefined
2015	970,48 mln. undefined	452,48 mln. undefined	354,25 mln. undefined
2014	761,05 mln. undefined	343,52 mln. undefined	287,12 mln. undefined
2013	614,00 mln. undefined	252,90 mln. undefined	220,00 mln. undefined
2012	333,00 mln. undefined	113,70 mln. undefined	155,90 mln. undefined
2011	196,70 mln. undefined	23,90 mln. undefined	58,70 mln. undefined

	Pajamos	EBIT	Pelnas
2011	196,70 mln. HKD	23,90 mln. HKD	58,70 mln. HKD
2012	333,00 mln. HKD	113,70 mln. HKD	155,90 mln. HKD
2013	614,00 mln. HKD	252,90 mln. HKD	220,00 mln. HKD
2014	761,05 mln. HKD	343,52 mln. HKD	287,12 mln. HKD
2015	970,48 mln. HKD	452,48 mln. HKD	354,25 mln. HKD
2016	1,08 mlrd. HKD	527,50 mln. HKD	420,32 mln. HKD
2017	1,27 mlrd. HKD	597,68 mln. HKD	489,97 mln. HKD
2018	1,51 mlrd. HKD	698,01 mln. HKD	580,72 mln. HKD
2019	1,43 mlrd. HKD	651,99 mln. HKD	556,12 mln. HKD
2020	1,32 mlrd. HKD	669,40 mln. HKD	542,46 mln. HKD
2021	1,56 mlrd. HKD	778,46 mln. HKD	607,84 mln. HKD
2022	1,73 mlrd. HKD	811,58 mln. HKD	645,88 mln. HKD
2023	1,52 mlrd. HKD	618,39 mln. HKD	540,39 mln. HKD
2024e	1,71 mlrd. HKD	748,73 mln. HKD	627,57 mln. HKD
2025e	1,94 mlrd. HKD	880,35 mln. HKD	734,30 mln. HKD
2026e	2,18 mlrd. HKD	1,01 mlrd. HKD	802,61 mln. HKD

2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e
0,20	0,33	0,61	0,76	0,97	1,08	1,27	1,51	1,43	1,32	1,56	1,73	1,52	1,71	1,94	2,18
-	69,90	84,38	23,94	27,46	11,75	16,70	19,60	−5,35	−8,17	18,33	11,25	−11,96	11,94	13,72	12,11
66,84	70,87	68,40	71,35	70,10	73,34	72,41	71,25	70,67	72,40	71,92	66,44	68,70	-	-	-
0,13	0,24	0,42	0,54	0,68	0,80	0,92	1,08	1,01	0,95	1,12	1,15	1,05	0	0	0
0,02	0,11	0,25	0,34	0,45	0,53	0,60	0,70	0,65	0,67	0,78	0,81	0,62	0,75	0,88	1,01
11,73	33,93	41,04	45,07	46,60	48,62	47,19	46,13	45,46	50,87	50,00	46,85	40,55	43,85	45,36	46,57
58,00	155,00	220,00	287,00	354,00	420,00	489,00	580,00	556,00	542,00	607,00	645,00	540,00	627,00	734,00	802,00
-	167,24	41,94	30,45	23,34	18,64	16,43	18,61	−4,14	−2,52	11,99	6,26	−16,28	16,11	17,07	9,26
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
402,90	600,00	749,30	830,00	835,99	837,10	837,10	837,10	837,10	837,10	837,10	837,10	837,10	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

0,16	0,24	0,92	1,03	1,28	1,58	1,90	2,27	1,97	1,85	2,28	2,24	2,38
18,30	22,80	112,70	127,38	171,12	144,58	170,77	176,93	313,04	546,45	526,48	923,23	395,24
3,60	1,10	1,10	1,11	1,11	1,11	1,11	1,11	1,11	0,97	0,97	18,77	27,74
0,06	0,08	0,10	0,12	0,16	0,18	0,24	0,24	0,32	0,50	0,43	0,47	1,01
14,10	173,80	19,10	36,22	41,44	48,82	49,69	58,45	43,11	43,01	41,93	27,33	30,99
0,26	0,51	1,16	1,32	1,65	1,96	2,35	2,75	2,64	2,93	3,28	3,68	3,84
163,40	110,60	212,60	262,54	262,76	257,23	265,54	289,17	395,37	392,25	411,81	405,07	436,81
1,90	24,30	14,40	25,86	23,08	33,12	36,08	35,65	29,53	23,87	63,36	62,61	59,80
0	0	0	0	0	0	0	0	0	0	16,06	18,77	0
0	0	0	0	11,92	31,86	29,58	72,49	60,67	54,84	60,95	59,71	56,39
0	0	0	0	49,42	49,42	49,42	0	0	0	0	0	0
59,40	20,80	24,50	24,49	25,61	26,54	25,14	27,32	8,94	13,06	22,05	14,81	37,12
224,70	155,70	251,50	312,89	372,79	398,18	405,77	424,62	494,51	484,02	574,23	560,98	590,12
0,49	0,67	1,41	1,63	2,03	2,35	2,76	3,17	3,14	3,42	3,85	4,24	4,43

201,40	201,40	415,00	415,00	938,79	938,79	938,79	938,79	938,79	938,79	938,79	938,79	938,79
3,90	3,90	452,40	0	0	0	0	0	0	0	0	0	0
0,12	0,28	0,40	0,62	0,89	1,20	1,56	1,98	1,74	2,08	2,48	2,69	2,95
12,10	14,50	6,10	−2,55	−14,64	−18,83	−6,51	−15,60	−18,11	−5,17	−4,51	−24,56	−24,90
0	0	0	0	0	0	0	0	0	0	0	0	0
0,34	0,49	1,27	1,03	1,82	2,12	2,49	2,91	2,66	3,02	3,42	3,60	3,87
20,80	44,00	46,80	38,16	35,35	36,24	52,68	51,72	65,91	74,13	34,60	153,71	422,39
10,80	11,50	22,30	32,72	41,64	52,13	61,81	62,36	74,76	62,27	88,45	77,03	65,22
19,70	41,80	27,00	20,13	35,73	34,52	32,97	26,69	126,76	39,35	36,81	145,49	31,30
0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0,17	39,65	40,86	53,20	42,35	56,42
51,30	97,30	96,10	91,01	112,72	122,89	147,45	140,93	307,08	216,62	213,06	418,57	575,33
0	0	0	0	0,56	0,56	0,61	1,05	60,23	65,15	75,27	60,73	75,39
4,70	3,80	4,20	4,68	4,79	4,14	4,42	4,87	5,38	5,70	7,15	7,18	8,44
20,20	0	0	0	0	0	0	0	0	0	−122,61	−134,86	0
24,90	3,80	4,20	4,68	5,35	4,69	5,02	5,93	65,60	70,84	−40,19	−66,95	83,84
76,20	101,10	100,30	95,68	118,07	127,59	152,48	146,86	372,68	287,46	172,87	351,63	659,16
0,42	0,60	1,37	1,13	1,93	2,25	2,65	3,05	3,03	3,30	3,59	3,96	4,53

2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022
77,00	198,00	271,00	355,00	456,00	532,00	610,00	720,00	689,00	685,00	778,00	825,00
10,00	10,00	14,00	17,00	22,00	23,00	26,00	30,00	79,00	78,00	69,00	75,00
0	0	0	0	0	0	0	0	0	0	0	0
−57,00	−37,00	−138,00	−117,00	−123,00	−84,00	−164,00	−155,00	−192,00	−633,00	−77,00	−346,00
38,00	14,00	−4,00	−10,00	−1,00	−3,00	−4,00	−17,00	−25,00	−14,00	6,00	−7,00
0	0	0	0	0	0	0	0	4,00	4,00	4,00	4,00
20,00	33,00	33,00	67,00	73,00	95,00	105,00	133,00	6,00	211,00	137,00	19,00
69,00	185,00	142,00	244,00	353,00	467,00	469,00	577,00	551,00	116,00	777,00	547,00
−62,00	−64,00	−126,00	−71,00	−26,00	−38,00	−34,00	−53,00	−16,00	−12,00	−23,00	−38,00
−36,00	−63,00	−475,00	−72,00	−68,00	−309,00	−381,00	−597,00	835,00	506,00	−265,00	335,00
25,00	2,00	−349,00	−1,00	−41,00	−271,00	−347,00	−544,00	852,00	519,00	−242,00	373,00
0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	−45,00	−45,00	−50,00	−56,00
0	0	699,00	0	0	0	0	0	0	0	0	0
−14,00	−14,00	540,00	−56,00	−80,00	−116,00	−141,00	−173,00	−878,00	−264,00	−278,00	−535,00
−14,00	−14,00	−58,00	10,00	2,00	−7,00	−7,00	−14,00	−37,00	−26,00	−27,00	−35,00
0	0	−100,00	−66,00	−83,00	−108,00	−133,00	−159,00	−795,00	−192,00	−200,00	−443,00
18,00	110,00	204,00	109,00	196,00	37,00	−47,00	−200,00	506,00	369,00	234,00	330,00
7,20	120,20	16,10	173,32	326,60	429,46	435,06	524,46	534,02	103,17	753,74	508,94
0	0	0	0	0	0	0	0	0	0	0	0

Beijing Tong Ren Tang Chinese Medicine Co Bruto marža	Beijing Tong Ren Tang Chinese Medicine Co Pelnas-martža	Beijing Tong Ren Tang Chinese Medicine Co EBIT marža	Beijing Tong Ren Tang Chinese Medicine Co Pelnas-martža
2026e	68,67 %	46,57 %	36,90 %
2025e	68,67 %	45,36 %	37,83 %
2024e	68,67 %	43,89 %	36,79 %
2023	68,67 %	40,55 %	35,44 %
2022	66,44 %	46,88 %	37,31 %
2021	71,95 %	50,02 %	39,06 %
2020	72,45 %	50,89 %	41,24 %
2019	70,69 %	45,51 %	38,82 %
2018	71,24 %	46,11 %	38,36 %
2017	72,39 %	47,21 %	38,70 %
2016	73,33 %	48,65 %	38,76 %
2015	70,16 %	46,62 %	36,50 %
2014	71,35 %	45,14 %	37,73 %
2013	68,40 %	41,19 %	35,83 %
2012	70,90 %	34,14 %	46,82 %
2011	67,01 %	12,15 %	29,84 %

	Bruto marža	EBIT marža	Pelnas-martža
2011	67,01 %	12,15 %	29,84 %
2012	70,90 %	34,14 %	46,82 %
2013	68,40 %	41,19 %	35,83 %
2014	71,35 %	45,14 %	37,73 %
2015	70,16 %	46,62 %	36,50 %
2016	73,33 %	48,65 %	38,76 %
2017	72,39 %	47,21 %	38,70 %
2018	71,24 %	46,11 %	38,36 %
2019	70,69 %	45,51 %	38,82 %
2020	72,45 %	50,89 %	41,24 %
2021	71,95 %	50,02 %	39,06 %
2022	66,44 %	46,88 %	37,31 %
2023	68,67 %	40,55 %	35,44 %
2024e	68,67 %	43,89 %	36,79 %
2025e	68,67 %	45,36 %	37,83 %
2026e	68,67 %	46,57 %	36,90 %

Data	Beijing Tong Ren Tang Chinese Medicine Co Pardavimai vienai akcijai	Beijing Tong Ren Tang Chinese Medicine Co EBIT vienai akcijai	Beijing Tong Ren Tang Chinese Medicine Co Pelnas vienai akcijai
2026e	2,60 undefined	0 undefined	0,96 undefined
2025e	2,32 undefined	0 undefined	0,88 undefined
2024e	2,04 undefined	0 undefined	0,75 undefined
2023	1,82 undefined	0,74 undefined	0,65 undefined
2022	2,07 undefined	0,97 undefined	0,77 undefined
2021	1,86 undefined	0,93 undefined	0,73 undefined
2020	1,57 undefined	0,80 undefined	0,65 undefined
2019	1,71 undefined	0,78 undefined	0,66 undefined
2018	1,81 undefined	0,83 undefined	0,69 undefined
2017	1,51 undefined	0,71 undefined	0,59 undefined
2016	1,30 undefined	0,63 undefined	0,50 undefined
2015	1,16 undefined	0,54 undefined	0,42 undefined
2014	0,92 undefined	0,41 undefined	0,35 undefined
2013	0,82 undefined	0,34 undefined	0,29 undefined
2012	0,56 undefined	0,19 undefined	0,26 undefined
2011	0,49 undefined	0,06 undefined	0,15 undefined

	Pardavimai vienai akcijai	EBIT vienai akcijai	Pelnas vienai akcijai
2011	0,49 HKD	0,06 HKD	0,15 HKD
2012	0,56 HKD	0,19 HKD	0,26 HKD
2013	0,82 HKD	0,34 HKD	0,29 HKD
2014	0,92 HKD	0,41 HKD	0,35 HKD
2015	1,16 HKD	0,54 HKD	0,42 HKD
2016	1,30 HKD	0,63 HKD	0,50 HKD
2017	1,51 HKD	0,71 HKD	0,59 HKD
2018	1,81 HKD	0,83 HKD	0,69 HKD
2019	1,71 HKD	0,78 HKD	0,66 HKD
2020	1,57 HKD	0,80 HKD	0,65 HKD
2021	1,86 HKD	0,93 HKD	0,73 HKD
2022	2,07 HKD	0,97 HKD	0,77 HKD
2023	1,82 HKD	0,74 HKD	0,65 HKD
2024e	2,04 HKD	0 HKD	0,75 HKD
2025e	2,32 HKD	0 HKD	0,88 HKD
2026e	2,60 HKD	0 HKD	0,96 HKD

	Akcijų skaičius
2011	402,90 mln. Aktien
2012	600,00 mln. Aktien
2013	749,30 mln. Aktien
2014	830,00 mln. Aktien
2015	835,99 mln. Aktien
2016	837,10 mln. Aktien
2017	837,10 mln. Aktien
2018	837,10 mln. Aktien
2019	837,10 mln. Aktien
2020	837,10 mln. Aktien
2021	837,10 mln. Aktien
2022	837,10 mln. Aktien
2023	837,10 mln. Aktien
2024e	837,10 mln. Aktien
2025e	837,10 mln. Aktien
2026e	837,10 mln. Aktien

Data	Beijing Tong Ren Tang Chinese Medicine Co Dividendas
2026e	0,72 undefined
2025e	0,71 undefined
2024e	0,72 undefined
2023	0,66 undefined
2022	0,53 undefined
2021	0,24 undefined
2020	0,23 undefined
2019	0,95 undefined
2018	0,19 undefined
2017	0,16 undefined
2016	0,13 undefined
2015	0,10 undefined
2014	0,08 undefined

	Dividendas	Dividenda (įvertinimas)
2011	0 HKD	0 HKD
2012	0 HKD	0 HKD
2013	0 HKD	0 HKD
2014	0,08 HKD	0 HKD
2015	0,10 HKD	0 HKD
2016	0,13 HKD	0 HKD
2017	0,16 HKD	0 HKD
2018	0,19 HKD	0 HKD
2019	0,95 HKD	0 HKD
2020	0,23 HKD	0 HKD
2021	0,24 HKD	0 HKD
2022	0,53 HKD	0 HKD
2023	0,66 HKD	0 HKD
2024e	0 HKD	0,72 HKD
2025e	0 HKD	0,71 HKD
2026e	0 HKD	0,72 HKD

Data	Beijing Tong Ren Tang Chinese Medicine Co Išmokėjimo santykis
2026e	49,81 %
2025e	54,53 %
2024e	49,16 %
2023	45,75 %
2022	68,69 %
2021	33,05 %
2020	35,49 %
2019	143,00 %
2018	27,39 %
2017	27,34 %
2016	25,89 %
2015	23,60 %
2014	23,13 %
2013	45,75 %
2012	45,75 %
2011	45,75 %

	Išmokėjimo santykis
2011	45,75 %
2012	45,75 %
2013	45,75 %
2014	23,13 %
2015	23,60 %
2016	25,89 %
2017	27,34 %
2018	27,39 %
2019	143,00 %
2020	35,49 %
2021	33,05 %
2022	68,69 %
2023	45,75 %
2024e	49,16 %
2025e	54,53 %
2026e	49,81 %

Data	EPS-prognozė	EPS-Faktinis	Pranešimo ketvirtis
2017-12-31	0,28	0,28 (1,67 %)	2017 Q4
2017-06-30	0,33	0,31 (−5,60 %)	2017 Q2

%	Pavadinimas	Akcijos	Pokytis	Data
38,05 %	Tong Ren Tang Technologies Co Ltd	318 540 000	0	2022-12-31
33,62 %	Beijing Tongrentang Co Ltd	281 460 000	0	2022-12-31
0,76 %	The Vanguard Group, Inc.	6 375 898	11 000	2024-03-31
0,75 %	China Merchants Fund Management Co. Ltd.	6 271 000	−651 000	2023-06-30
0,65 %	Value Partners Ltd.	5 440 000	−200 000	2023-12-31
0,48 %	Bosera Asset Management Co., Ltd.	4 028 000	983 000	2023-12-31
0,48 %	E Fund Management Co. Ltd.	4 010 848	130 729	2023-12-31
0,48 %	BlackRock Institutional Trust Company, N.A.	3 997 000	0	2024-03-31
0,42 %	Ceresio Investors	3 497 000	0	2022-12-31
0,38 %	Dimensional Fund Advisors, L.P.	3 172 000	−58 000	2024-02-29
0,29 %	China Universal Asset Management Co., Ltd.	2 457 000	1 788 000	2023-06-30
0,14 %	China Asset Management Co., Ltd.	1 149 000	1 149 000	2023-06-30
0,11 %	Fullgoal Fund Management Co., Ltd.	952 000	−1 037 000	2023-12-31
0,11 %	China Southern Asset Management Co. Ltd.	881 000	881 000	2023-06-30
0,08 %	AllianceBernstein L.P.	690 000	0	2024-02-29
0,08 %	BlackRock Advisors (UK) Limited	682 337	1 000	2024-03-31
0,08 %	American Century Investment Management, Inc.	639 000	0	2024-03-31
0,07 %	Union Investment Luxembourg S.A.	615 000	0	2023-12-31
0,07 %	Dodge & Cox	563 700	150 000	2024-03-31
0,05 %	Charles Schwab Investment Management, Inc.	439 699	0	2024-03-31
0,05 %	Ding (Yong Ling)	430 000	0	2023-08-31
0,05 %	PensionDanmark A/S	405 965	405 965	2023-08-31
0,04 %	Zhong Ou Asset Management Co., Ltd.	355 000	355 000	2023-06-30
0,04 %	Lin (Man)	310 000	0	2023-09-12
0,04 %	RAM Active Investments S.A.	302 754	−326 246	2023-12-31
0,03 %	Penghua Fund Management Co., Ltd.	267 000	42 000	2023-12-31
0,03 %	Dimensional Fund Advisors, Ltd.	238 000	−99 000	2024-02-29
0,03 %	Truvalue Asset Management Co., Ltd.	216 000	216 000	2023-06-30
0,02 %	Nuveen LLC	205 000	0	2024-03-31
0,02 %	California State Teachers Retirement System	201 000	201 000	2023-06-30
0,02 %	Geode Capital Management, L.L.C.	157 000	0	2024-02-29
0,02 %	State Street Global Advisors (US)	151 000	−2 000	2024-02-29
0,02 %	Parametric Portfolio Associates LLC	130 000	0	2024-02-29
0,01 %	Yinhua Fund Management Co., Ltd.	99 000	64 000	2023-12-31
0,01 %	KGI Securities Investment Trust Company Ltd.	89 095	−1 407	2023-12-31
0,01 %	Avantis Investors	76 000	0	2024-03-31
0,01 %	State Street Global Advisors Ireland Limited	72 000	0	2024-03-31
0,01 %	Western Leadbank Fund Management Co., Ltd.	70 000	70 000	2023-12-31
0,01 %	Allianz Global Investors GmbH	67 000	42 000	2024-01-31
0,01 %	HSBC Global Asset Management (UK) Limited	44 861	26 390	2024-01-31
0,01 %	Chen (Fei)	43 000	0	2022-12-31
0,00 %	DFA Australia Ltd.	38 958	31 958	2023-12-31
0,00 %	Huashang Fund Management Co., Ltd.	29 000	29 000	2023-12-31
0,00 %	Allianz Global Investors U.S. LLC_NLE	25 000	0	2023-10-31
0,00 %	Ping An Fund Management Company Limited	18 000	3 000	2023-06-30
0,00 %	Vanguard Global Advisers LLC	16 000	0	2024-03-31
0,00 %	Dimensional Fund Advisors Canada ULC	11 000	0	2023-11-30
0,00 %	Eaton Vance Management	9 914	151	2024-02-29
0,00 %	Anfield Capital Management, LLC	6 627	0	2022-12-31
0,00 %	Northern Trust Investments, Inc.	5 000	0	2024-03-31
0,00 %	Mackenzie Financial Corporation	2 000	2 000	2024-03-31
0 %	Finlabo SIM S.p. A.	0	−24 000	2024-02-29
0 %	Manulife Investment Management (M) Berhad	0	−431 000	2023-09-30
0 %	Cinda Fund Management Co., Ltd.	0	−38 000	2023-12-31
0 %	Franklin Templeton Sealand Fund Management Co., Ltd.	0	−679 000	2023-06-30
0 %	JPMorgan Asset Management (China) Company Limited.	0	−98 000	2023-12-31
0 %	Oberweis Asset Management, Inc.	0	−230 000	2023-09-30
0 %	Acadian Asset Management LLC	0	−59 000	2023-05-31
0 %	Asset Management One Co., Ltd.	0	−5 000	2023-11-30
0 %	SEB Investment Management AB	0	−74 540	2022-11-30
0 %	Irish Life Investment Managers Ltd.	0	−11 675	2022-11-30
0 %	Robeco Institutional Asset Management B.V.	0	−81 000	2024-02-29
0 %	Manulife Investment Management (North America) Limited	0	−901 000	2023-09-30
0 %	Grantham Mayo Van Otterloo & Co LLC	0	−16 000	2022-11-30
0 %	CI Global Asset Management	0	−60 252	2022-11-30
0 %	Mellon Investments Corporation	0	−2 124 800	2022-11-30

Pavadinimas	Santykis	Dviejų savaičių koreliacija	Vieno mėnesio koreliacija	Trymėnesio koreliacija	Šešių mėnesių koreliacija	Vienmečio koreliacija	Dviejų metų koreliacija
Tong Ren Tang Techs H	TiekėjasKlientas	0,45	0,21	0,35	0,88	0,81	0,84
Beijing Tong Ren Tang A	TiekėjasKlientas	0,06	-0,43	0,11	0,51	0,51	0,66

What values and corporate philosophy does Beijing Tong Ren Tang Chinese Medicine Co represent?

Beijing Tong Ren Tang Chinese Medicine Co Ltd represents a strong commitment to traditional Chinese medicine (TCM) and the values of quality, integrity, and innovation. With a rich history dating back to 1669, the company has been dedicated to providing authentic TCM products and services globally. Beijing Tong Ren Tang embraces a corporate philosophy centered around the preservation and advancement of TCM, while upholding strict standards in manufacturing and research. The company's emphasis on customer satisfaction, scientific advancements, and cultural heritage has positioned it as a leading provider of high-quality Chinese medicine products in the market.

In which countries and regions is Beijing Tong Ren Tang Chinese Medicine Co primarily present?

Beijing Tong Ren Tang Chinese Medicine Co Ltd primarily operates in China, its country of origin. As one of the oldest and most renowned traditional Chinese medicine (TCM) companies, its presence is mainly focused within the mainland. With a rich history dating back over 350 years, Beijing Tong Ren Tang has expanded its reach beyond China, establishing subsidiaries and distribution networks in various countries and regions worldwide. However, its core operations remain centered in China, where it continues to be a leading provider of high-quality TCM products and services.

What significant milestones has the company Beijing Tong Ren Tang Chinese Medicine Co achieved?

Some significant milestones achieved by Beijing Tong Ren Tang Chinese Medicine Co Ltd include the company's establishment in 1669 during the Qing Dynasty, making it one of the oldest Chinese medicine companies in operation. With a rich history spanning over three centuries, Beijing Tong Ren Tang has become a renowned and trusted brand globally for traditional Chinese medicine products. The company has received numerous accolades and awards for its commitment to quality and authenticity. It has also expanded its presence internationally, with branches in various countries. Beijing Tong Ren Tang continues to innovate and uphold the principles of traditional Chinese medicine, contributing to the health and well-being of individuals worldwide.

What is the history and background of the company Beijing Tong Ren Tang Chinese Medicine Co?

Beijing Tong Ren Tang Chinese Medicine Co Ltd is a renowned company with a rich history and background. Established in 1669, it has a legacy of over 350 years in the Chinese medicine industry. As one of the oldest and most prestigious traditional Chinese medicine companies, Beijing Tong Ren Tang has become synonymous with excellence in herbal medicine and healthcare products. With a mission to preserve and promote the wisdom of traditional Chinese medicine, the company has expanded globally, serving customers worldwide. Today, Beijing Tong Ren Tang continues to be a trusted name, offering high-quality, authentic herbal products derived from centuries of expertise in Chinese medicine.

Who are the main competitors of Beijing Tong Ren Tang Chinese Medicine Co in the market?

Beijing Tong Ren Tang Chinese Medicine Co Ltd faces competition from several companies in the market. Some of its main competitors include Shanghai Traditional Chinese Medicines Group, China Resources Sanjiu Medical & Pharmaceutical Co Ltd, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, and Tasly Pharmaceutical Group Co Ltd. These companies also operate in the traditional Chinese medicine industry and offer similar products and services, posing a challenge to Beijing Tong Ren Tang Chinese Medicine Co Ltd's market position.

In which industries is Beijing Tong Ren Tang Chinese Medicine Co primarily active?

Beijing Tong Ren Tang Chinese Medicine Co Ltd is primarily active in the pharmaceutical and healthcare industries.

What is the business model of Beijing Tong Ren Tang Chinese Medicine Co?

The business model of Beijing Tong Ren Tang Chinese Medicine Co Ltd is focused on the production and distribution of traditional Chinese medicine products. With a rich history dating back to 1669, the company applies stringent quality control measures to ensure the effectiveness and safety of its remedies. Beijing Tong Ren Tang is recognized for its proprietary knowledge in herbal medicine, providing a wide range of products including herbal decoctions, health tonics, and external use formulations. By adhering to traditional Chinese medicine principles, the company aims to promote overall health and wellbeing through its products. Beijing Tong Ren Tang Chinese Medicine Co Ltd continues to uphold its reputation as a leading provider of trusted and authentic Chinese medicine worldwide.

Koks yra Beijing Tong Ren Tang Chinese Medicine Co 2024 KGV?

Beijing Tong Ren Tang Chinese Medicine Co KGV yra 11,62.

Koks Beijing Tong Ren Tang Chinese Medicine Co 2024 KUV?

Beijing Tong Ren Tang Chinese Medicine Co KUV yra 4,27.

Koks yra Beijing Tong Ren Tang Chinese Medicine Co AlleAktien kokybės įvertinimas?

AlleAktien kokybės įvertis Beijing Tong Ren Tang Chinese Medicine Co yra 8/10.

Koks yra Beijing Tong Ren Tang Chinese Medicine Co 2024 pajamų dydis?

tikėtina Beijing Tong Ren Tang Chinese Medicine Co pardavimai yra 1,71 mlrd. HKD.

Kokia yra Beijing Tong Ren Tang Chinese Medicine Co 2024 pelnas?

tikėtina Beijing Tong Ren Tang Chinese Medicine Co pelnas yra 627,57 mln. HKD.

Ką daro Beijing Tong Ren Tang Chinese Medicine Co?

Beijing Tong Ren Tang Chinese Medicine Co Ltd is one of the largest and most well-known companies for Chinese medicine worldwide. Founded in 1669, the company has a long and rich history. Today, Beijing Tong Ren Tang operates in more than 50 countries and offers a variety of products and services related to Chinese medicine. The core business of Beijing Tong Ren Tang is in the field of traditional Chinese medicine. The company produces and distributes traditional herbal medicine, pharmaceuticals, and dietary supplements. High-quality natural raw materials are used and processed according to traditional methods. The products are offered worldwide through a network of distribution partners in pharmacies, drugstores, and online shops. In addition to the production of Chinese medicine, Beijing Tong Ren Tang also offers a variety of healthcare services. Traditional examination methods and diagnostic procedures are used to analyze the body's health condition and create individual therapy plans. Through close cooperation with doctors and clinics in China and other countries, patients can receive comprehensive care. Another significant aspect of Beijing Tong Ren Tang is the promotion of Chinese medicine culture and education. The company organizes workshops, seminars, and courses to train professionals and those interested in Chinese medicine. Additionally, Beijing Tong Ren Tang aims to promote Chinese culture and its medical traditions worldwide. Through research and development, Beijing Tong Ren Tang continuously works on exploring new healing methods and developing innovative products. Modern scientific knowledge is combined with the wisdom of traditional Chinese medicine. The goal is to provide patients with the best possible therapy and treatment. Overall, Beijing Tong Ren Tang's business model is focused on sustainable and long-term development. The company emphasizes high-quality products, tradition and innovation, and close collaboration with customers and partners worldwide. The goal of Beijing Tong Ren Tang is to promote health and well-being through the application of Chinese medicine and to promote Chinese culture.

Kokia yra Beijing Tong Ren Tang Chinese Medicine Co dividendė?

Beijing Tong Ren Tang Chinese Medicine Co moka dividendą 0,53 HKD, kuris yra paskirstytas per išmokas per metus.

Kiek kartų Beijing Tong Ren Tang Chinese Medicine Co moka dividendą?

Dividenda šiuo metu negali būti apskaičiuota Beijing Tong Ren Tang Chinese Medicine Co arba įmonė dividendų nemoka.

Kas yra Beijing Tong Ren Tang Chinese Medicine Co ISIN?

Beijing Tong Ren Tang Chinese Medicine Co ISIN yra HK0000145638.

Kas yra Beijing Tong Ren Tang Chinese Medicine Co WKN?

Beijing Tong Ren Tang Chinese Medicine Co WKN yra A1XDB1.

Kas yra Beijing Tong Ren Tang Chinese Medicine Co Tickeris?

Beijing Tong Ren Tang Chinese Medicine Co akcijų simbolis yra 3613.HK.

Kiek dividendų moka Beijing Tong Ren Tang Chinese Medicine Co?

Per paskutinius 12 mėnesių Beijing Tong Ren Tang Chinese Medicine Co išmokėjo dividendą, kurios dydis siekė 0,66 HKD . Tai atitinka maždaug 7,58 % dividendų grąžą. Artimiausiems 12 mėnesiams Beijing Tong Ren Tang Chinese Medicine Co tikėtina išmokės dividendus, kurie sudarys 0,71 HKD.

Kokia yra Beijing Tong Ren Tang Chinese Medicine Co dividendų grąža?

Beijing Tong Ren Tang Chinese Medicine Co šiuo metu yra 7,58 % dydžio dividendų grąža.

Kada Beijing Tong Ren Tang Chinese Medicine Co moka dividendus?

Beijing Tong Ren Tang Chinese Medicine Co moka dividendus kas ketvirtį. Jie išmokami lapkritis, birželis, liepa, liepa mėnesiais.

Kokia saugi yra Beijing Tong Ren Tang Chinese Medicine Co dividendų išmokėjimas?

Beijing Tong Ren Tang Chinese Medicine Co per paskutiniuosius 13 metus kiekvienais metais mokėjo dividendus.

Kokia yra Beijing Tong Ren Tang Chinese Medicine Co dividendų suma?

Artimiausiems 12 mėnesiams tikimasi dividendų, kurių dydis yra 0,71 HKD. Tai atitinka 8,19 % dividendų grąžos procentą.

Kokiame sektoriuje yra Beijing Tong Ren Tang Chinese Medicine Co?

Beijing Tong Ren Tang Chinese Medicine Co priskiriamas sektoriui "Sveikata".

Wann musste ich die Aktien von Beijing Tong Ren Tang Chinese Medicine Co kaufen, um die vorherige Dividende zu erhalten?

Norėdamas gauti paskutinį Beijing Tong Ren Tang Chinese Medicine Co dividendą nuo 2024-06-24, kurio dydis yra 0,33 HKD, turėjai turėti akciją savo depozite prieš ex-dieną, kuri buvo 2024-06-12.

Kada Beijing Tong Ren Tang Chinese Medicine Co paskutinį kartą mokėjo dividendą?

Paskutinės dividendų išmokėjimas įvyko 2024-06-24.

Kokia buvo Beijing Tong Ren Tang Chinese Medicine Co dividendų suma 2023 metais?

2023 metais Beijing Tong Ren Tang Chinese Medicine Co išmokėjo 0,53 HKD dividendų.

Kokia valiuta Beijing Tong Ren Tang Chinese Medicine Co moka dividendus?

Beijing Tong Ren Tang Chinese Medicine Co dividendai yra mokami HKD.

Birža	Beijing Tong Ren Tang Chinese Medicine Co Akcijų kodas
FRANKFURTAS	TQR.F
HKSE	3613.HK
PNK	BJTRF

Beijing Tong Ren Tang Chinese Medicine Co Akcijų kodas	Beijing Tong Ren Tang Chinese Medicine Co FIGI
3613:HK	BBG004HNJ6Q0
TQR:GR	BBG004M1K4B1
TQR:GF	BBG004M1K4C0
8138N:PO	BBG00JRF9BN6
8138N:L3	BBG00JRFD876
8138N:B3	BBG00JRFG668
8138HKD:X2	BBG00JRGDDK8
8138HKD:XB	BBG00JRGDDL7
8138HKD:XH	BBG00JRGDDN5
8138HKD:XF	BBG00JRGDDQ2
8138HKD:XE	BBG00JRGDDS0
8138HKD:XJ	BBG00JRGDDT9
8138HKD:XL	BBG00JRGDDV6
8138HKD:XG	BBG00JRGDDW5
8138HKD:XO	BBG00JRGDDX4
8138HKD:XS	BBG00JRGDF14
8138HKD:XA	BBG00JRGDF23
8138HKD:E1	BBG00JRGDF32
8138HKD:XT	BBG00JRGDF41
8138HKD:XW	BBG00JRGDF50
8138HKD:XU	BBG00JRGDF69
8138HKD:XV	BBG00JRGDF78
8138HKD:XM	BBG00JRGDF87
8138HKD:XQ	BBG00JRGDFB3
8138HKD:XX	BBG00JRGDFC2
8138HKD:XZ	BBG00JRGDFD1
8138HKD:EU	BBG00JRGDFG8
BJTRF:US	BBG00L02VYP2
BJTRF:PQ	BBG00L02VZ33
BJTRF:UV	BBG00L02VZ42
3613:H2	BBG00LYLGDM9
8138N:L1	BBG00Y7B2K15
3613:H1	BBG01FRSRHQ9

Padaryk geriausias savo gyvenimo investicijas fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Kursas

Akcijos kaina

Akcijų kodas3613.HK

ISINHK0000145638

VVPA1XDB1

Beijing Tong Ren Tang Chinese Medicine Co akcijų kaina

Kursas

Apžvalga

Intraday funkcija

Bendroji grąža ir santykinė kainų pokyčiai

Interpretacija ir investavimas

Beijing Tong Ren Tang Chinese Medicine Co Akcijų istorija

Beijing Tong Ren Tang Chinese Medicine Co akcijų apyvarta, EBIT, pelnas HK0000145638 · A1XDB1

Pajamos, pelnas & EBIT

Supratimas apie pajamas, EBIT ir pelną

Metinė analizė ir palyginimai

Išnaudoti lūkesčius investuojant

Investicijų įžvalgos

Beijing Tong Ren Tang Chinese Medicine Co Pajamų, pelno ir EBIT istorija.

Beijing Tong Ren Tang Chinese Medicine Co Akcijų rodikliai

GuV

Pajamos ir augimas

Bruto marža

EBIT ir EBIT marža

Pajamos ir jų augimas

Leidžiamų akcijų skaičius

Metinių duomenų palyginimo interpretacija

Lūkesčiai ir prognozės

Balansas

Balanso supratimas

Turtas

Įsipareigojimai

Nuosavas kapitalas

Metų po metų analizė

Duomenų interpretacija

Beijing Tong Ren Tang Chinese Medicine Co Akcijos Maržos HK0000145638 · A1XDB1

Margen

Supratimas apie bruto maržą

EBIT maržos analizė

Pardavimų maržos įžvalgos

Lūkesčių interpretavimas

Lyginamoji analizė

Beijing Tong Ren Tang Chinese Medicine Co Maržų istorija

Beijing Tong Ren Tang Chinese Medicine Co akcijos apyvarta, EBIT, pelnas vienai akcijai HK0000145638 · A1XDB1

Pardavimai, EBIT ir Pelnas vienai akcijai

Pajamos vienai akcijai

EBIT vienai akcijai

Pelnas vienai akcijai

Tikėtinos vertės

Beijing Tong Ren Tang Chinese Medicine Co Pardavimų, pelno ir EBIT istorija vienai akcijai

Beijing Tong Ren Tang Chinese Medicine Co akcija ir akcijų analizė

Beijing Tong Ren Tang Chinese Medicine Co vertinimas pagal Fair Value

Fair Value

Supratimas apie Fair Value

Pajamų pagrindu skaičiuojamas Fair Value

Apyvartos pagrindu skaičiuojamas Fair Value

Dividendų pagrindu skaičiuojamas Fair Value

Lūkesčiai ir prognozės

Palyginamoji analizė

Beijing Tong Ren Tang Chinese Medicine Co įvertinimas pagal istorinį P/E, EBIT ir P/S

Beijing Tong Ren Tang Chinese Medicine Co akcijų skaičius HK0000145638 · A1XDB1

Pardavimai, EBIT ir Pelnas vienai akcijai

Pajamos vienai akcijai

EBIT vienai akcijai

Pelnas vienai akcijai

Tikėtinos vertės

Beijing Tong Ren Tang Chinese Medicine Co akcijos dividendas HK0000145638 · A1XDB1

Dividendas

Dividendų apžvalga

Interpretacija ir naudojimas

Investavimo strategija

Beijing Tong Ren Tang Chinese Medicine Co Dividendų istorija

Beijing Tong Ren Tang Chinese Medicine Co akcijų išmokėjimo koeficientas HK0000145638 · A1XDB1

Dividendų mokėjimo rodiklis

Kas yra metinis dividendų mokėjimo rodiklis?

Kaip interpretuoti duomenis

Duomenų naudojimas investavimui

Beijing Tong Ren Tang Chinese Medicine Co Dividendų išmokėjimo istorija

Beijing Tong Ren Tang Chinese Medicine Co Pelno prognozės

Padaryk geriausias savo gyvenimo investicijas
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Akcijų kodas
3613.HK

ISIN
HK0000145638

VVP
A1XDB1